États-Unis · Plateformes & données · Yahoo Finance

Mestag Therapeutics Appoints Philip Astley-Sparke and Victor Sandor, M.D.C.M., to its Board of Directors

Publié par Yahoo Finance · États-Unis il y a 8 h

Mr. Astley-Sparke brings more than two decades of biotech leadership, having scaled several highly innovative transatlantic companies, including Replimune, uniQure and BioVex --…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

Mestag Therapeutics Appoints Philip Astley-Sparke and Victor Sandor, M.D.C.M., to its Board of Directors

À lire aussi

DNOW Inc. (NYSE:DNOW) Stock Rated "Moderate Buy" by Sell-Side Brokerages

It’s a rough housing market, and Goldman Sachs expects it to get worse

President Donald Trump Claims, "We Don't Have Inflation, and Tariffs Don't Cause Inflation," but a New Report Strongly Disagrees

U.S. to allow 'dark fleet' tankers to ship oil legally

France imposes curfews in parts of Paris, other cities after weekend of riots

The world’s finance chiefs see new risks — and less China angst

Mestag Therapeutics Appoints Philip Astley-Sparke and Victor Sandor, M.D.C.M., to its Board of Directors

Partager

À lire aussi

DNOW Inc. (NYSE:DNOW) Stock Rated "Moderate Buy" by Sell-Side Brokerages

It’s a rough housing market, and Goldman Sachs expects it to get worse

President Donald Trump Claims, "We Don't Have Inflation, and Tariffs Don't Cause Inflation," but a New Report Strongly Disagrees

U.S. to allow 'dark fleet' tankers to ship oil legally

France imposes curfews in parts of Paris, other cities after weekend of riots

The world’s finance chiefs see new risks — and less China angst